We are a spinoff company of the Foundation for Research and Technology - Hellas (FORTH) and the University of Crete.
We develop advanced patient-tailored treatments using proprietary technologies
Our Technology
We provide expertise in
-
precision biofabrication
-
active biomaterial development
-
stem cell culture and differentiation
-
cell and animal models of neurodegeneration
-
animal models of CNS injury
-
imaging
-
robotics
Neuroimplants
We develop novel treatments for Central Nervous System Injuries consisting of potent Stem Cells and inside bioactive ​biomaterials
Relevant Publications
-
Kourgiantaki A., et al. Neural stem cell delivery via porous collagen scaffolds promotes neuronal differentiation and locomotion recovery in spinal cord injury. NPJ Regen Med 5:12, 2020. doi: 10.1038/s41536-020-0097-0.
-
Georgelou K., et al. Microneurotrophin BNN27 Reduces Astrogliosis and Increases Density of Neurons and Implanted Neural Stem Cell-Derived Cells after Spinal Cord Injury. Biomedicines 11(4):1170, 2023. doi: 10.3390/biomedicines11041170.
-
Georgelou K., et al. Delivery of Microneurotrophin BNN27 via Collagen Glycosaminoglycan Scaffold - FmocFF Hydrogel Grafts Promotes Neuroprotection after Optic Nerve Injury. J Biomed. Mat. Res. B: 114(1):e70013, 2026. doi: 10.1002/jbmb.70013
Our Team
Achilleas Gravanis, CEO, co-founder
Ex Professor of Pharmacology; Medical School, University of Crete. Ex affiliated Researcher; IMBB-FORTH. Affiliated Professor; Faculty of Pharmacy, Northeastern University, USA. Affiliated Principal Investigator; Emulate Co, USA. Venture partner; BigPi Ventures. Venture partner; Olivetree Venture Capital. Served as member of the Biomedical Research Program Committee of the European Commission. Co-founder of biotechnology spinoffs BioNature Ltd and ReNeuroCell Therapeutics.
Dimitrios Tzeranis, CSO, co-founder
Assistant Professor; Material Science & Engineering, University of Crete. Affiliated Faculty; IMBB-FORTH. Founder of FORTH/UoC Biomaterials & Medical Devices Lab. Expertise: bioengineering, mechanical engineering, biomaterials, biofabrication, imaging, robotics.
Ioannis Charalampopoulos, COO, co-founder
Professor of Pharmacology; Medical School, University of Crete & Clinical Pharmacology Laboratory, University General Hospital. Researcher; IMBB-FORTH. Fellow; Dept of Neuroscience, Karolinska Medical School. Ex Director, Graduate Program in Neurosciences, Medical School, University of Crete. Partner; Bionature Ltd.
Gregory Roumeliotis, Chief Strategy Officer
​​Precision Medicine Go-to-Market Strategist with major background in Health Technology Assessment and tech trasnfers. Multiomics / genomics - NGS technologies integration expert.
Pioneer in the establishment and development of biobanking & cell therapy preclinical services.
Emmanuel Stratakis, co-founder
Research Director and Acting Director IESL-FORTH. Head; Ultrafast Laser Micro- and Nano- processing laboratory. Director; FORTH European Nanoscience Facility. National expert in the High-Level Group of EU on Nanotechnologies, Advanced Materials, Biotechnology, Advanced Manufacturing and Processing. Member; COST Scientific Committee. Founder and CEO; FORTH spinoff Biomimetic.
Konstantinos Fotakis, co-founder
Emeritus Professor of Physics; University of Crete. Distinguished Member; FORTH.
Former Alternate Minister for Research and Innovation (January 2015 to July 2019).